These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 3945219
1. Oral contraceptive agents. Shearman RP. Med J Aust; 1986 Feb 17; 144(4):201-5. PubMed ID: 3945219 [Abstract] [Full Text] [Related]
3. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Godsland IF, Crook D, Devenport M, Wynn V. Contraception; 1995 Sep 17; 52(3):143-9. PubMed ID: 7587185 [Abstract] [Full Text] [Related]
4. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V. Contracept Fertil Sex (Paris); 1985 Jan 17; 13(1 Suppl):425-30. PubMed ID: 12280210 [Abstract] [Full Text] [Related]
5. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST. Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404 [Abstract] [Full Text] [Related]
6. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K. Contraception; 1992 Jun 01; 45(6):523-32. PubMed ID: 1535580 [Abstract] [Full Text] [Related]
7. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women. Gaspard UJ, Deville JL, Dubois M. Curr Med Res Opin; 1983 Jun 01; 8(6):395-404. PubMed ID: 6406157 [Abstract] [Full Text] [Related]
8. Latest views on pill prescribing. Kay CR. J R Coll Gen Pract; 1984 Nov 01; 34(268):611-4. PubMed ID: 6502571 [Abstract] [Full Text] [Related]
9. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW, Chenault CB, de la Peña A, Dozier TS, Kraemer DC. Fertil Steril; 1978 Nov 01; 30(5):522-33. PubMed ID: 214353 [Abstract] [Full Text] [Related]
10. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419 [Abstract] [Full Text] [Related]
11. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R. Contraception; 1985 Apr 11; 31(4):395-408. PubMed ID: 3159546 [Abstract] [Full Text] [Related]
12. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel. Gaspard UJ, Dubois M, Gillain D, Franchimont P, Duvivier J. Contraception; 1984 Apr 11; 29(4):305-18. PubMed ID: 6430638 [Abstract] [Full Text] [Related]
13. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES, Cruickshank J, McMaster M, Weir RJ. Br J Obstet Gynaecol; 1984 Dec 11; 91(12):1254-60. PubMed ID: 6440589 [Abstract] [Full Text] [Related]
14. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids. Scott JA, Brenner PF, Kletzky OA, Mishell DR. Am J Obstet Gynecol; 1978 Apr 01; 130(7):817-21. PubMed ID: 345817 [Abstract] [Full Text] [Related]